|
|
|||
|
||||
OverviewThis account of the aetiology, diagnosis, management and future trends in bladder cancer starts by addressing epidemiological questions, before going on to discuss the molecular factors influencing carcinoma of the bladder. Also covered are disease and prognosis issues, and new therapies, including biological response modifier, photodynamic treatments and new drugs. The authors aim to address the controversial issues surrounding this topic and provide a consensus of opinion. Full Product DetailsAuthor: William R Fair , Francesco Pagano , Francesco Pagano , William R. FairPublisher: ISIS Medical Media Ltd Imprint: ISIS Medical Media Ltd Weight: 0.998kg ISBN: 9781899066537ISBN 10: 1899066535 Pages: 350 Publication Date: 01 April 1997 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: Awaiting stock Table of Contents1. Epidemiology of bladder cancer 2. Bladder cancer as a molecular disease 3. Current issues in the pathology of superficial bladder cancer 4. Natural history and prognosis of 'untreated' and 'treated' superficial bladder cancer 5. Prognostic factors: back to the future 6. Towards a better knowledge of bladder cancer 7. Rationale and principles of intravesical therapy 8. Methodology in superficial bladder cancer trials 9. Objective response criteria to intravesical chemotherapy 10. Overview on Doxorubicin and Epirubicin 11. Overview on Mitomycin C (MMC) 12. Overview on Bacillus Calmette-Guerin 13. The use of biological modifiers in the treatment of superficial bladder cancer 14. Intravesical chemotherapy versus immunotherapy 15. Photodynamic therapy of bladder carcinoma 16. Unresponsive superficial bladder cancer 17. Bladder cancer and automated nuclear morphological grading 18. The management of TI bladder tumor: conservative therapy 19. The management of TI tumor: the case for aggressive treatment 20. Carcinoma in situ 21. Follow-up of patients with 'superficial' transitional cell carcinoma of the bladder: time to reflect 22. Satisfaction with life during intravesical immuno-therapy with Bacillus Calmette-Guerin - a pilot studyReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||